Q&A: Part 2 of 2: Denise Juliano, Group Vice President of Life Sciences, Premier

This interview is provided in two parts. Part One covered Retrospective and Clinical Trial Data, Actionable Data, Real World Evidence, and Improvement Science. Part Two discusses Real World Data, Social Drivers of Health, Patient-Centric Care Model, and Health Equity Index.

ROH: Welcome back to Part Two of this Interview! You have impressive real-world data! How do you foresee hospitals, health systems, and life sciences organizations leveraging this data to generate Real World Experience?

DJ: During the COVID-19 pandemic, clinicians scrambled to find a vaccine, and life sciences organizations searched for up-to-date Real-World Experience.

The PAS team developed a Special Release of the pre-pandemic baseline data and clinically validated data from 2020 and forward. Data was made available for licensing to the Centers for Disease Control and Prevention, the National Institute of Health, life sciences organizations, and academia to conduct research studies on COVID-19 timely, resulting in more than 50 studies, many of which have been published in peer-reviewed journals.

Life sciences and medical device organizations are utilizing Real World Data to generate Real World Experience. One life sciences company recently leveraged data from our database to support its Breakthrough Designation request and 510 (k) regulatory filing. Their use of the data set helped them prove their device, with expanded indications, was substantially equivalent to using the predicate device, thus clearing the product of additional randomized clinical trials and testing.

Researchers are also seeking data on social drivers of health (SDOH), including their impact on outcomes, costs, and healthcare resource utilization. With the Centers for Medicare and Medicaid Services requiring providers to screen and report on SDOH starting in 2024, information must be collected about food insecurity, housing status, transportation needs, financial challenges, and interpersonal safety concerns. This data can provide a longitudinal view of the patient journey, illuminating critical touchpoints in care and opportunities to incorporate patient preferences, needs, values, and goals.

The PAS team is cultivating strategic collaborations, engaging in peer-to-peer knowledge sharing, and developing prospective research and evidence generation to support decision-making.

Read full article here.